Variants of the coronavirus avoid antibody treatments. New lab options can help.
Comment this story Comment In the evolutionary chess match between the coronavirus and humans, scientists’ next move can’t come soon enough for the millions of Americans who depend on treatments known as monoclonal antibodies. These lab-made therapies are rapidly losing their healing power, forcing researchers around the world to design new antibodies that are both …
Variants of the coronavirus avoid antibody treatments. New lab options can help. Read More »